Manufacturer
Sanofi-Aventis
Pharmaceutical manufacturer based in France
France
- Products listed
- 62
- Molecules
- 25
- Therapy areas
- 11
Sanofi-Aventis is a pharmaceutical manufacturer based in France. MedsAcross lists 62 of its products across 25 molecules, each with registers, packs and availability for export supply to licensed buyers.
- Country
- France
- Indian manufacturer
- No
- Also listed as
- Sanofi-Aventis, Sanofi-Aventis U.S. LLC, sanofi-aventis U.S. LLC
- EU marketing authorisation holder
- YesSource: European Medicines Agency
- US FDA labeler
- YesSource: openFDA NDC directory
Source from this manufacturer
We supply Sanofi-Aventis products through licensed channels, with the documents your regulator needs.
Haematology
18 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Enoxaparin 100 mg/1 mL injectionSubcutaneousGeneric name | Enoxaparin | US FDA | Available on request |
| Enoxaparin 120 mg/0.8 mL injectionSubcutaneousGeneric name | Enoxaparin | US FDA | Available on request |
| Enoxaparin 150 mg/1 mL injectionSubcutaneousGeneric name | Enoxaparin | US FDA | Available on request |
| Enoxaparin 30 mg/0.3 mL injectionSubcutaneousGeneric name | Enoxaparin | US FDA | Available on request |
| Enoxaparin 300 mg/3 mL injectionSubcutaneousGeneric name | Enoxaparin | US FDA | Available on request |
| Enoxaparin 40 mg/0.4 mL injectionSubcutaneousGeneric name | Enoxaparin | US FDA | Available on request |
| Enoxaparin 60 mg/0.6 mL injectionSubcutaneousGeneric name | Enoxaparin | US FDA | Available on request |
| Enoxaparin 80 mg/0.8 mL injectionSubcutaneousGeneric name | Enoxaparin | US FDA | Available on request |
| Lovenox 100 mg/1 mL injectionSubcutaneous | Enoxaparin | US FDA | Available on request |
| Lovenox 120 mg/0.8 mL injectionSubcutaneous | Enoxaparin | US FDA | Available on request |
| Lovenox 150 mg/1 mL injectionSubcutaneous | Enoxaparin | US FDA | Available on request |
| Lovenox 30 mg/0.3 mL injectionSubcutaneous | Enoxaparin | US FDA | Available on request |
| Lovenox 300 mg/3 mL injectionIntravenous, subcutaneous | Enoxaparin | US FDA | Available on request |
| Lovenox 40 mg/0.4 mL injectionSubcutaneous | Enoxaparin | US FDA | Available on request |
| Lovenox 60 mg/0.6 mL injectionSubcutaneous | Enoxaparin | US FDA | Available on request |
| Lovenox 80 mg/0.8 mL injectionSubcutaneous | Enoxaparin | US FDA | Available on request |
| Plavix 300 mg tabletOral | Clopidogrel | US FDA | Available on request |
| Plavix 75 mg tabletOral | Clopidogrel | US FDA | Available on request |
Diabetes
12 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Admelog 100 units/mL injectionIntravenous, subcutaneous Cold chain | Insulin lispro | US FDA | Available on request |
| Admelog 100 units/mL injectionSubcutaneous Cold chain | Insulin lispro | US FDA | Available on request |
| Apidra 100 IU/mL injectionIntravenous, subcutaneous Cold chain | Insulin glulisine | US FDA | Available on request |
| Apidra SoloStar 100 IU/mL injectionSubcutaneous Cold chain | Insulin glulisine | US FDA | Available on request |
| Insulin glargine U-300 300 IU/mL injectionSubcutaneous Cold chain | Insulin glargine | US FDA | Available on request |
| Insulin glargine U-300 Max 300 IU/mL injectionSubcutaneous Cold chain | Insulin glargine | US FDA | Available on request |
| Lantus 100 IU/mL injectionSubcutaneous Cold chain | Insulin glargine | US FDA | Available on request |
| Lantus Solostar 100 IU/mL injectionSubcutaneous Cold chain | Insulin glargine | US FDA | Available on request |
| Merilog 100 IU/mL injectionIntravenous, subcutaneous Cold chain | Insulin aspart | US FDA | Available on request |
| Soliqua 100/33 100 units/33 mcg per mL injectionSubcutaneous Cold chain | Insulin glargine and Lixisenatide | US FDA | Available on request |
| Toujeo 300 units/mL injectionSubcutaneous Cold chain | Insulin glargine | US FDA | Available on request |
| TOUJEO Max 300 units/mL injectionSubcutaneous Cold chain | Insulin glargine | US FDA | Available on request |
Oncology
9 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Docetaxel 160 mg/8 mL injectionIntravenousGeneric name | Docetaxel | US FDA | Available on request |
| Docetaxel 20 mg/1 mL injectionIntravenousGeneric name | Docetaxel | US FDA | Available on request |
| Docetaxel 80 mg/4 mL injectionIntravenousGeneric name | Docetaxel | US FDA | Available on request |
| Jevtana kit | Cabazitaxel | US FDA | Available on request |
| Sarclisa 100 mg/5 mL injectionIntravenous Cold chain | Isatuximab | US FDA | Available on request |
| Sarclisa 500 mg/25 mL injectionIntravenous Cold chain | Isatuximab | US FDA | Available on request |
| Sarclisa Escena 1400 mg/10 mL injectionSubcutaneous Cold chain | Isatuximab | US FDA | Available on request |
| Zaltrap 100 mg/4 mL injectionIntravenous Cold chain | Aflibercept | US FDA | Available on request |
| Zaltrap 200 mg/8 mL injectionIntravenous Cold chain | Aflibercept | US FDA | Available on request |
Cardiology
7 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Avalide 12.5 mg/150 mg tabletOral | Hydrochlorothiazide and Irbesartan | US FDA | Available on request |
| Avalide 12.5 mg/300 mg tabletOral | Hydrochlorothiazide and Irbesartan | US FDA | Available on request |
| Avapro 150 mg tabletOral | Irbesartan | US FDA | Available on request |
| Avapro 300 mg tabletOral | Irbesartan | US FDA | Available on request |
| Multaq 400 mg tabletOral | Dronedarone | US FDA | Available on request |
| Praluent 150 mg/1 mL injectionSubcutaneous Cold chain | Alirocumab | US FDA | Available on request |
| Praluent 75 mg/1 mL injectionSubcutaneous Cold chain | Alirocumab | US FDA | Available on request |
Immunology and transplant
5 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Arava 10 mg tabletOral | Leflunomide | US FDA | Available on request |
| Arava 100 mg tabletOral | Leflunomide | US FDA | Available on request |
| Arava 20 mg tabletOral | Leflunomide | US FDA | Available on request |
| Kevzara 150 mg/1.14 mL injectionSubcutaneous Cold chain | Sarilumab | US FDA | Available on request |
| Kevzara 200 mg/1.14 mL injectionSubcutaneous Cold chain | Sarilumab | US FDA | Available on request |
Nephrology and urology
3 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Sevelamer 2400 mg powder for oral suspensionOralGeneric name | Sevelamer | US FDA | Available on request |
| Sevelamer 800 mg tabletOralGeneric name | Sevelamer | US FDA | Available on request |
| Sevelamer 800 mg powder for oral suspensionOralGeneric name | Sevelamer | US FDA | Available on request |
Dermatology
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Dupixent 200 mg/1.14 mL injectionSubcutaneous Cold chain | Dupilumab | US FDA | Available on request |
| Dupixent 300 mg/2 mL injectionSubcutaneous Cold chain | Dupilumab | US FDA | Available on request |
Antidotes
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Elitek kit Cold chain | Rasburicase | US FDA | Available on request |
Immune stimulants
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Mozobil 24 mg/1.2 mL injectionSubcutaneous | Plerixafor | US FDA | Available on request |
Tuberculosis
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Priftin 150 mg tabletOral | Rifapentine | US FDA | Available on request |
Malaria
1 presentation
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Primaquine 15 mg tabletOralGeneric name | Primaquine | US FDA | Available on request |
Other products
2 presentations
| Medicine | Active ingredient | Register | Availability |
|---|---|---|---|
| Ferrlecit 62.5 mg/5 mL injectionIntravenous | Sodium ferric gluconate complex | US FDA | Available on request |
| Fexinidazole 600 mg tabletOralGeneric name | Fexinidazole | US FDA | Available on request |
Molecules made
Insulin lisproInsulin glulisineLeflunomideHydrochlorothiazide and IrbesartanIrbesartanDocetaxelDupilumabRasburicaseEnoxaparinSodium ferric gluconate complexFexinidazoleInsulin glargineCabazitaxelSarilumabInsulin aspartPlerixaforDronedaroneClopidogrelAlirocumabRifapentinePrimaquineIsatuximabSevelamerInsulin glargine and LixisenatideAflibercept
Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.
Source from Sanofi-Aventis
Send a request for any of these products. We confirm the licensed source, documents and lead time.